Infectious Disease
Rapid and precise detection of low-abundance pathogens and viral load monitoring using digital PCR.
Explore Our Diagnostic Test Portfolios
Available Tests: 7
Multiple Infectious Disease
Mycobacterium tuberculosis Complex cfDNA
Quantitative detection of Mycobacterium
tuberculosis DNA in plasma cell-free DNA (cfDNA)
is performed using digital PCR. This assay supports
studies on pathogen identification in critical,
pediatric, or low-volume sampling cases.
Multiplex Viral Encephalitis & Meningitis Pathogens
Digital PCR-based detection of 20 common
neurotropic viruses is performed. This assay
supports auxiliary studies in hospitalized
or critically ill patients with suspected viral
meningoencephalitis.
Multiplex Bloodstream Infecton Pathogens
Detection of 19 common Gram-negative and
Gram-positive bacteria and fungi, along with
7 antimicrobial resistance genes, is performed
directly from peripheral blood using digital PCR.
This assay supports rapid pathogen research
without the need for culture enrichment.
Multiplex Respiratory Pathogens
Quantitative detection of 11 common upper and
lower respiratory pathogens (viruses, bacteria, and
Mycoplasma) is performed using digital PCR. This
assay supports research related to respiratory
infection etiology.
Enterovirus Universal
Specific primers and probes targeting enterovirus
RNA are used for digital PCR-based quantitative
detection. This assay supports studies on
enteroviral infection in clinical or epidemiological
settings.
ctHPV Detection and Genetype
Quantitative detection of 14 high- and
intermediate-risk human papillomavirus (HPV)
DNA types is performed using digital PCR in female
plasma samples, including HPV 16, 18, 31, 33, 35,
39, 45, 51, 52, 56, 58, 59, 66, and 68. Genotyping is
supported, although HPV 59/68 and 56/66 are
not differentiated. This assay supports studies on
treatment response evaluation and recurrence
monitoring related to minimal residual disease
(MRD) in cervical cancer.
SARS-CoV-2
Quantitative detection of SARS-CoV-2 RNA is
performed using digital PCR, targeting the ORF1ab
and N genes. This assay supports studies on
COVID-19 viral load and molecular epidemiology.